Skip to content

Influence of an Endometrioma on Oocyte Quality

Influence of an Endometrioma on Oocyte Quality

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03352661
Acronym
ENDOVOC
Enrollment
80
Registered
2017-11-24
Start date
2017-01-31
Completion date
2018-01-31
Last updated
2017-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

The purpose of this study is to evaluate if there are differences in oocyte quality depending on whether these oocytes come from an ovary in contact with an endometrioma.

Detailed description

There is no consensus for whether an endometrioma influences oocyte quality, as well as the possible mechanisms that induce them. In this study, the oocyte maturation will proof oocyte quality: This mean, the percentage of oocytes in metaphase II obtained after stimulation, as well as the rate of oocytes fertilized in direct contact with an endometrioma.

Interventions

Collect retrospectively data

Sponsors

IVI Vigo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Patients \<40 years, BMI \<30kg / m2,

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Percentage of mature oocytesUp to 36 monthsNumber of MII oocytes from the total of cumulus granulosa cell-oocyte complex by 100
Fertilization rateUp to 36 monthsNumber of oocytes with pronuclear activation after ICSI procedure from the total oocytes microinjected by 100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026